Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

New England Journal of Medicine

Volumn 300, Issue 19, 1979, Pages 1068-1073

  Weiden, Paul L ^a,b   Flournoy, Nancy ^a,b   Thomas, E Donnall ^a,b   Prentice, Ross ^a,b   Fefer, Alexander ^a,b   Buckner, C Dean ^a,b   Storb, Rainer ^a,b  

^a FRED HUTCHINSON CANCER RESEARCH CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW TRANSPLANTATION; GRAFT VERSUS HOST REACTION; HEREDITY; LEUKEMIA; MAJOR CLINICAL STUDY; THERAPY;

EID: 0018764352     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197905103001902     Document Type: Article

References (30)

1. Thomas ED, Storb R, Clift RA, et al: Bone-marrow transplantation. N Engl J Med 292: 832–843; 895–902, 1975
2. Thomas ED, Buckner CD, Banaji M, et al: One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49: 511–533, 1977
3. Fefer A, Einstein AB Jr, Cheever MA: Adoptive chemoimmunotherapy of cancer in animals: a review of results, principles, and problems. Ann NY Acad Sci 277: 492–504, 1976
4. Fefer A: Adoptive tumor immunotherapy in mice as an adjunct to whole-body X-irradiation and chemotherapy: a review. Isr J Med Sci 9: 350–365, 1973
5. Glucksberg H, Storb R, Fefer A, et al: Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18: 295–304, 1974
6. Neiman PE, Reeves W, Ray G, et al: A prospective analysis of interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. J Infect Dis 136: 754–767, 1977
7. Cox DR: Regression models and life-tables. J R Statist Soc [B] 34: 187–220, 1972
8. Kalbfleisch JD, Prentice RL: Marginal likelihoods based on Cox's regression and life model. Biometrika 60: 267–278, 1973
9. Prentice RL, Kalbfleisch JD, Peterson AV Jr, et al: The analysis of failure times in the presence of competing risks. Biometrics 34: 541–554, 1978
10. Thomas ED, Buckner CD, Fefer A, et al: Marrow transplantation in the treatment of acute leukemia. Adv Cancer Res 27: 269–279, 1978
11. Shulman HM, Sale GE, Lerner KG, et al: Chronic cutaneous graft-versus-host disease in man. Am J Pathol 91: 545–570, 1978
12. Weiden PL, Doney K, Storb R, et al: Anti-human thymocyte globulin (ATG) for prophylaxis and treatment of graft-versus-host disease in recipients of allogeneic marrow grafts. Transplant Proc 10: 213–216, 1978
13. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Statist Assoc 53: 457–481, 1958
14. Peto R, Peto J: Asymptotically efficient rank invariant test procedures. J R Statist Soc [A] 135: 185–206, 1972
15. Breslow N: A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship. Biometrika 57: 579–594, 1970
16. Barnes DWH, Loutit JF: Treatment of murine leukaemia with x-rays and homologous bone marrow. Br J Haematol 3: 241–252, 1957
17. de Vries MJ, Vos O: Treatment of mouse lymphosarcoma by total-body X irradiation and by injection of bone marrow and lymph-node cells. J Natl Cancer Inst 21: 1117–1129, 1958
18. Mathé G, Schwarzenberg L, Amiel AL, et al: Experimental basis and clinical results of leukemia adoptive immunotherapy. Recent Results Cancer Res 30: 76–84, 1970
19. Bortin MM, Rimm AA, Saltzstein EC, et al: Graft versus leukemia. III. Apparent independent antihost and antileukemic activity of transplanted immunocompetent cells. Transplantation 16: 182–188, 1973
20. Bortin MM, Rimm AA, Rose WC, et al: Graft-versus-leukemia. V. Absence of antileukemic effect using allogeneic H-2-identical immunocompetent cells. Transplantation 18: 280–283, 1974
21. Boranic M: Transplantability of leukaemia from leukaemic mice after irradiation and injection of allogeneic spleen cells. Rev Eur Etud Clin Biol 15: 104–109, 1970
22. Pollard M, Truitt RL: Allogeneic bone marrow chimerism in germ-free mice. I. Prevention of spontaneous leukemia in AKR mice. Proc Soc Exp Biol Med 144: 659–665, 1973
23. Truitt RL, Pollard M, Srivastava KK: Allogeneic bone marrow chimerism in germ-free mice. III. Therapy of leukemic AKR mice. Proc Soc Exp Biol Med 146: 153–158, 1974
24. Truitt RL, Pollard M: Allogeneic bone marrow chimerism in germ-free mice. IV. Therapy of “Hodgkin's-like” reticulum cell sarcoma in SJL mice. Transplantation 21: 12–16, 1976
25. Kende M, Keys LD, Gaston M, et al: Immunochemotherapy of transplantable Moloney leukemia with cyclophosphamide and allogeneic spleen lymphocytes and reversal of graft-vermi-host disease with alloantiserum. Cancer Res 35: 346–351, 1975
26. Chester SJ, Esparza AR, Flinton LJ, et al: Further development of a successful protocol of graft versus leukemia without fatal graft-versus-host disease in AKR mice. Cancer Res 37: 3494–3496, 1977
27. Weiden PL, Storb R, Sale GE, et al: Allogeneic hematopoieic grafts after total-body irradiation in dogs with spontaneous tumors. J Natl Cancer Inst 61: 353–357, 1978
28. Thomas ED, Flournoy N, Buckner CD, et al: Cure of leukemia by marrow transplantation. Leuk Res 1: 67–70, 1977
29. Fefer A, Buckner CD, Thomas ED, et al: Cure of hematologic neoplasia with transplantation of marrow from identical twins. N Engl J Med 297: 146–148, 1977
30. Odom LF, August CS, Githens JH, et al: Remission of relapsed leukaemia during a graft-versus-host reaction: a “graft-versus-leukaemia reaction” in man? Lancet 2: 537–540, 1978